The mer/axl/tyro3 subfamily of tyrosine kinases (TAM kinases) plays a powerful role in regulating activation of macrophages, dendritic cells, and NK cells by diverting cytokine production from inflammatory to noninflammatory cytokines. These receptor kinases bind to phospholipid-binding proteins which in turn bind to phospholipids, notably phosphatidylserine on apoptotic cells. These signaling molecules can thus down regulate innate immunity when they bind to dying cells or other phospholipid-containing debris. We propose to perform the first studies of these important molecules in humans and in human disease. The central hypothesis of this proposal is that these key regulatory molecules can be harnessed as potential targets for immunotherapy of lupus and other inflammatory and autoimmine disorders. The first Specific Aim is to define which human immune cells - and subsets of cells - express these molecules. In the second Aim, we will ask how expression is regulated during immune activation and cell maturation. We are especially interested in the possibility that the immunomodulatory role of immune complexes might be mediated through mer, and that the composition of immune complexes, notably their phospholipid content, may be of importance in mer cross linking. In the third Specific Aim, we will test whether cross linking of mer/axl/tyro3 (individually and together) leads to down regulation of macrophage, dendritic cell, NK cell, and lymphocyte activation in vitro. These studies will lead the way to developing an important potential therapeutic target for treatment of autoimmune and inflammatory disorders. In the fourth Specific Aim, we will examine expression of these molecules in human SLE peripheral blood, hypothesizing that this autoimmune condition may be characterized by increased expression of these kinases. We will ask whether the overexpression of type I interferon-related genes (the lupus """"""""signature"""""""") can be diminished by cross linking of these immunoregulatory kinases. Such experiments may give support to the notion that therapeutic ligation of these receptor kinases could be used to control autoimmunity and inflammation.
These studies are relevant to the overall mission of the ACE as they will contribute to understanding of a specific autoimmune disorder but will very likely have applications to other disases and to immunoregulation in humans in general. They are related to the T-cell cytokine polarization studies in that macrophage and DC activation is key to this process;and to the proposed stem cell transfer experiments looking at SLE immunoregulatiory disorders.
|Xie, Chong; Ciric, Bogoljub; Yu, Shuo et al. (2016) IL-12R?2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis. J Neuroimmunol 291:59-69|
|Rasouli, Javad; Ciric, Bogoljub; Imitola, Jaime et al. (2015) Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-? Therapy. J Immunol 194:5085-93|
|Lee, Iris J; Hilliard, Brendan A; Ulas, Mehriban et al. (2015) Monocyte and plasma expression of TAM ligand and receptor in renal failure: Links to unregulated immunity and chronic inflammation. Clin Immunol 158:231-41|
|Shao, Wen-Hai; Zhen, Yuxuan; Finkelman, Fred D et al. (2014) The Mertk receptor tyrosine kinase promotes T-B interaction stimulated by IgD B-cell receptor cross-linking. J Autoimmun 53:78-84|
|Fitzgerald, Denise C; Fonseca-Kelly, Zoë; Cullimore, Melissa L et al. (2013) Independent and interdependent immunoregulatory effects of IL-27, IFN-?, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis. J Immunol 190:3225-34|
|Zizzo, Gaetano; Cohen, Philip L (2013) IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids. J Immunol 190:5237-46|
|Zizzo, Gaetano; Guerrieri, Justus; Dittman, Lindsay M et al. (2013) Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity. Arthritis Res Ther 15:R212|
|Zizzo, Gaetano; Hilliard, Brendan A; Monestier, Marc et al. (2012) Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol 189:3508-20|
|Chen, David R; Cohen, Philip L (2012) Living life without B cells: is repeated B-cell depletion a safe and effective long-term treatment plan for rheumatoid arthritis? Int J Clin Rheumtol 7:159-166|
|Shao, Wen-Hai; Zhen, Yuxuan; Finkelman, Fred D et al. (2012) Intrinsic unresponsiveness of Mertk-/- B cells to chronic graft-versus-host disease is associated with unmodulated CD1d expression. J Autoimmun 39:412-9|
Showing the most recent 10 out of 18 publications